Signet Financial Management LLC Cuts Stake in AbbVie Inc. $ABBV

robot
Abstract generation in progress

Signet Financial Management LLC reduced its stake in AbbVie Inc. by 39.2% in the third quarter, selling 16,186 shares and holding 25,094 shares valued at $5.81 million. Despite this, other institutional investors either bought new positions or adjusted their holdings. AbbVie (NYSE:ABBV) currently holds a “Moderate Buy” consensus rating from analysts with an average target price of $251.56, and recently reported strong quarterly earnings and revenue exceeding expectations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)